healthcare
healthcare Articles
Tilray released fourth-quarter financial results after the closing bell on Monday. The company said that it had a net loss of $0.62 per share and $46.94 million in revenue, compared with consensus...
Published:
Tilray is scheduled to release its most recent quarterly results after the markets close on Monday.
Published:
Forty Seven shares skyrocketed on Monday after the company announced that it would be acquired by Gilead Sciences. But is Gildead paying too much?
Published:
As COVID-19 spreads, the chance that at least some NBA games will be played in empty areas is rising.
Published:
These stocks that are either defensive in general or are defying the big drop because they have some aspect of their business that might be immune to daily scares or because they are potential...
Published:
Mylan stock pulled back on Friday after it reported mixed fourth-quarter financial results late Thursday.
Published:
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Novavax shares made a big step forward on Wednesday after the firm provided an update on its treatment for COVID-19.
Published:
Day two of the coronavirus scare is now in the books and practically all major American averages are down over 3% for their second consecutive day. Currently all the gains for the year for each of...
Published:
The broad markets are getting crushed on Monday on renewed fears of the spread of the coronavirus (Covid-19). But a handful of stocks were acting as a natural hedge to the virus news.
Published:
Karyopharm Therapeutics shares made a handy gain on Wednesday after the firm secured a key FDA nod for its relapsed or refractory diffuse large B-cell lymphoma treatment.
Published:
Researchers have conducted a trial of a device that alerts anesthesiologists to a possible low-blood-pressure event for patients in surgery. The alerts come 15 minutes before the event could occur.
Published:
Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly contraceptive patch. Yet, one analyst sees great long-term potential, targeting the...
Published: